FDA just launched TEMPO, a digital health strategy that can come as a boon for people with chronic ailments.
Category: Drug of the week
Durvalumab Approved by FDA: Here’s What You Should KnowDurvalumab Approved by FDA: Here’s What You Should Know
Durvalumab, a monoclonal antibody gets a nod from the FDA to be used in resectable stomach cancers. Read more for full story.
Amoxicillin-Clavulanate- Latest ResearchAmoxicillin-Clavulanate- Latest Research
This week featuring drug of the week is Amoxicillin-Clavunate, a pediatric combination antibacterial drug. Click to read full post.
Semaglutide- boon or bane for weight lossSemaglutide- boon or bane for weight loss
Explore how GLP-1 receptor agonists are transforming healthcare. Read more in this week’s Drug of the Week on BioDiaries.
Letrozole: From Breast Cancer to Fertility and BeyondLetrozole: From Breast Cancer to Fertility and Beyond
In today's drug of the week series, explore letrozole’s role in cancer treatment, fertility, and emerging research breakthroughs.
Atropine Sulphate – A Key Agent in Pupil DilationAtropine Sulphate – A Key Agent in Pupil Dilation
Atropine Sulphate, in the form of eye drops in used in regular eye examinations apart from being prescribed for myopia and bradycardia.